Navigation Links
New England Journal of Medicine releases study showing GSK's FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children
Date:12/11/2013

for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.  FluLaval Quadrivalent is approved for use in persons 3 years of age and older.

Indication for Fluarix Quadrivalent

Fluarix Quadrivalent is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.  Fluarix Quadrivalent is approved for use in persons 3 years of age and older.

Important Safety Information for FluLaval Quadrivalent and Fluarix Quadrivalent

  • Do not administer FluLaval Quadrivalent or Fluarix Quadrivalent to anyone with known severe allergic reactions (anaphylaxis) to any component of the vaccine, including egg protein, or a life‐threatening reaction to previous administration of any influenza vaccine.
  • If Guillain-Barre syndrome has occurred within 6 weeks of receipt of a prior influenza vaccine, the decision to give FluLaval Quadrivalent or Fluarix Quadrivalent should be based on careful consideration of the potential benefits and risks.
  • The tip caps of the Fluarix Quadrivalent prefilled syringes may contain natural rubber latex which may cause allergic reactions in latex-sensitive individuals.
  • Syncope (fainting) can occur in association with administration of injectable vaccines. Procedures should be in place to avoid falling injury and to restore cerebral perfusion following syncope
  • If FluLaval Quadrivalent or Fluarix Quadrivalent is administered to immunosuppressed persons, including individuals receiving immunosuppressive therapy, the immune response may be lower than in immunocompetent persons.
  • In clinical trials with FluLaval Quadrivalent, the most common solicited local adverse reaction in adults was pain.  The most common solicited systemic adverse reactions
    '/>"/>

SOURCE GlaxoSmithKline plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System
2. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
3. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
4. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
5. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
6. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiƫnten voor 44% minder bloedstroominfecties zorgt
7. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
8. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
9. New England Biolabs Releases a New Fast, Low-Nanogram Input Library Prep Method for DNA and RNA Sequencing
10. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
11. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/15/2014)... 2014  A novel wearable injector slightly larger than an Oreo ... to self-inject prescription drugs in the large doses required to ... autoimmune deficiencies, and genetic disorders.  An emerging ... 2018, according to analysts.   Many of these drugs will require ...
(Date:1/14/2014)... The Brandeis Medical Center, led by Dr. Emmanuel Brandeis , ... laser tattoo removal experience with the advanced Astanza Duality laser and ... quality cosmetic services with cutting edge medical technology and offering expert ... has seen a dramatic increase in the presence of ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 2011 A new report in the March issue of ... beat brand names when it comes to safety, efficacy, and ... drug programs offering these drugs at prices as low as ... Walgreens, and Walmart have been steadily expanding their discount programs, ...
... JumpStart Ventures , the non-profit that invests in ... Ohio, and Cleveland Clinic , announced a ... Inc. The Cleveland-based company is developing a topical ... formation in wounds. (Logo: http://photos.prnewswire.com/prnh/20060209/CLJUMPSTARTLOGO) ...
Cached Medicine Technology:Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 2Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 3Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 4JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 2JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 3JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 4
(Date:7/9/2014)... users in Russia might contribute to HIV transmission ... by researchers from Boston University Schools of Medicine ... Pavlov State University, sought to discover the effect ... a cohort of HIV-positive people with lifetime of ... by police were more likely to share needlesincreasing ...
(Date:7/9/2014)... 8, 2014) Researchers from Montefiore Medical Center ... of Yeshiva University will present new findings at ... 12 July 17 in Copenhagen, Denmark. Data from ... prompt transition from cognitive normality to mild cognitive impairment ... Einstein Aging Study , established in 1980 to examine ...
(Date:7/9/2014)... organs in the human body. Its job is to ... is its synthesis function and that toxic substances ... detoxification function. Lack of exercise and too much alcohol, ... resulting diseased cells can lead to inflammations, cancerous ulcers, ... the German Liver Foundation, over five million people in ...
(Date:7/9/2014)... City, July 9, 2014 A study published in ... De Koninck and Robert Bonin, two researchers at Universit ... hypersensitivity using a new method that involves rekindling pain ... could lead to novel means to alleviate chronic pain. ... Universit Laval and Institut universitaire en sant mentale de ...
(Date:7/8/2014)... Department of Defense,s Defense Advanced Research Projects Agency ... to $2.5 million to develop an implantable neural ... neurons within the brain to help restore memory, ... builds on the understanding that memory is a ... the brain encode information, store it and retrieve ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Discovery of a new means to erase pain 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3
... FARMINGDALE, N.Y., Sept. 1 Misonix, Inc., (Nasdaq: ... technology, which in Europe is used for the ablation of ... the second expansion of its direct sales channel for the ... addition to its already established, commission based, contract sales organization, ...
... , ELM GROVE, Wis., Sept. 1 Compirion ... prevent child abuse. During the month of September, Compirion ... awareness of the devastating effects of abuse and neglect on our ... and more than two thousand die at the hands of those ...
... , , , ... community public health plan, today announced that it has received the Department ... a leader in quality care throughout the state of California for Medi-Cal ... and humbled by the recognition," said Dr. Kelly Pfeifer, SFHP Medical Director. ...
... , , ... launched its sixth season of the Thrive advertising campaign, with television, ... commitment to the total health of its members and the communities ... "Emerald Cities" and "Connected" -- illustrate Kaiser Permanente,s leadership in leveraging ...
... , , WASHINGTON, Sept. ... the country today announced an unprecedented alliance that will add ... group, Employers for Quality Health Care, is an independent coalition ... business groups like the U.S. Chamber of Commerce and the ...
... , , FDA won,t disclose brands; still ... FRANCISCO, Sept. 1 A study by the Food and Drug Administration found ... for Safe Cosmetics (CSC) in a 2007 study that received international attention. ... tested, at 0.09 to 3.06 parts per million - four times higher than ...
Cached Medicine News:Health News:Misonix Expands Sales Organization for Direct Sales of the SonicOne(TM) Wound Management System and the SonaStar(R) Ultrasonic Surgical Aspirator in the United States 2Health News:Misonix Expands Sales Organization for Direct Sales of the SonicOne(TM) Wound Management System and the SonaStar(R) Ultrasonic Surgical Aspirator in the United States 3Health News:Compirion Joins the Fight Against Child Abuse 2Health News:San Francisco Health Plan Recognized as Top Health Plan for Quality in the California Medi-Cal Program 2Health News:San Francisco Health Plan Recognized as Top Health Plan for Quality in the California Medi-Cal Program 3Health News:Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 2Health News:Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 3Health News:Employers Launch Grassroots Health Reform Coalition 2Health News:Employers Launch Grassroots Health Reform Coalition 3Health News:FDA Study: Lead Levels in Lipstick Much Higher Than Previously Reported 2
... indoor positioning supports patient safety by ... the right patients are in the ... Respond to the exact patient location ... monitor alarms. Measure patient flow times ...
... are preominantly used for routine blood collection. ... of the needle protective cap simplifies visual ... example, yellow symbolises the needle dimension 20 ... mm) and black 22 G (0.70 mm). ...
DiaMed-ID Micro Typing System...
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
Medicine Products: